Clemens Muehlan

11PUBLICATIONS
20CO-AUTHORS
Dental therapeutics, pharmacology and toxicologyPharmacogenomicsBiomechanicsInter-organisational, extra-organisational and global information systemsToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 06, 2024
Nighttime safety of daridorexant: Evaluation of responsiveness to an external noise stimulus, postural stability, walking, and cognitive function.

Massimo Magliocca, Ingrid Koopmans, Cedric Vaillant

|Aug 09, 2024
Pharmacokinetics, safety, and efficacy of daridorexant in Japanese subjects: Results from phase 1 and 2 studies.

Makoto Uchiyama, Kazuo Mishima, Tomoko Yagi

|Jul 09, 2024
The interactive walkway provides fit-for-purpose fall-risk biomarkers in the elderly: Comparison of zolpidem and suvorexant.

Ingrid Koopmans, Daphne Geerse, Lara de Ridder

|Apr 22, 2023
The orexin story and orexin receptor antagonists for the treatment of insomnia.

Clemens Muehlan, Catherine Roch, Cedric Vaillant

|Oct 30, 2022
Population pharmacokinetic modeling of daridorexant, a novel dual orexin receptor antagonist.

Andreas Krause, Dominik Lott, Janneke M Brussee

|Jun 14, 2021
Pharmacokinetics of daridorexant, a dual orexin receptor antagonist, are not affected by renal impairment.

Benjamin Berger, Clemens Muehlan, Gernot Klein

Pageof 2